Krainer Adrian R. 4
4 · Stoke Therapeutics, Inc. · Filed Jun 8, 2022
Insider Transaction Report
Form 4
Krainer Adrian R.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-06-07+21,000→ 21,000 totalExercise: $12.96Exp: 2032-06-06→ Common Stock (21,000 underlying)
Footnotes (1)
- [F1]The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.